Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Open Access
- 1 January 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (3), 1599-1604
- https://doi.org/10.1074/jbc.m507892200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the ProteasomeNeuron, 2004
- Alzheimer Disease in the US PopulationArchives of Neurology, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 FibrilsScience, 2001
- Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APPScience, 2001
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cellsNature Medicine, 1997
- Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptidesNature Medicine, 1997
- Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42Journal of Biological Chemistry, 1997
- Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formationProceedings of the National Academy of Sciences, 1997